Physician
Infectious Disease
Dr. Sam T. Donta, MD
|
|
Give Review
Sam T. Donta practices Infectious Disease. He studied medicine at Albert Einstein College of Medicine of Yeshiva University. Donta has written publications. He has 85 publications published with PubMed. The lastest paper is: 'Statistical evaluation of the role of Helicobacter pylori in stress gastritis: applications of splines and bootstrapping to the logistic model.' Donta accepts Medicare payments and is listed with Medicare.gov.
Publications
- Subjective symptoms after treatment of Lyme disease.
- Lyme disease guidelines--it's time to move forward.
- The antibiotic treatment trial of Gulf War Veterans' Illnesses: issues, design, screening, and baseline characteristics.
- Research on informed consent: investigator-developed versus focus group-developed consent documents, a VA cooperative study.
- Late and chronic Lyme disease.
- Predictors of exercise compliance in individuals with Gulf War veterans illnesses: Department of Veterans Affairs Cooperative Study 470.
- Benefits and harms of doxycycline treatment for Gulf War veterans'' illnesses: a randomized, double-blind, placebo-controlled trial.
- Macrolide therapy of chronic Lyme Disease.
- Cognitive behavioral therapy and aerobic exercise for Gulf War veterans'' illnesses: a randomized controlled trial.
- A multicenter two by two factorial trial of cognitive behavioral therapy and aerobic exercise for Gulf War veterans' illnesses: design of a veterans affairs cooperativ...
- Long-term outcomes of Lyme disease.
- Immunotherapy of sepsis: flawed concept or faulty implementation?
- Statistical evaluation of the role of Helicobacter pylori in stress gastritis: applications of splines and bootstrapping to the logistic model.
- A review of the design of vaccine efficacy trials and a proposal for the design of the VA Cooperative Study of Active Immunotherapy of HIV Infection.
- Tetracycline therapy for chronic Lyme disease.
- Risk factors for upper gastrointestinal bleeding in intensive care unit patients: role of helicobacter pylori. Federal Hyperimmune Immunoglobulin Therapy Study Group.
- Immunoprophylaxis against klebsiella and pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study Group.
- Physician preferences in the diagnosis and treatment of Lyme disease in the United States.
- Inhibition of heat-labile cholera and Escherichia coli enterotoxins by brefeldin A.
- Inhibition of beta-adrenergic binding by fungal metabolites.
- Inhibition of Shiga-like toxins by brefeldin A.
- Neonatal antibiotic-associated colitis.
- Cephalosporin-associated colitis and Clostridium difficile.
- Gap junction assembly and endocytosis correlated with patterns of growth in a cultured adrenocortical tumor cell (SW-13).
- Factors associated with creatinine clearance changes following gentamicin therapy.
- Prophylactic antibiotics in general surgery: a medical opinion.
- Rationales expressed by empiric antibiotic prescribers.
- The new cephalosporins.
- Differential effects of Clostridium difficile toxins on tissue-cultured cells.
- Clostridium difficile toxin in asymptomatic neonates.
- Sulindac-induced aseptic meningitis.
- Comparison of the binding of cholera and Escherichia coli enterotoxins to Y1 adrenal cells.
- Clostridium difficile toxin A in infants.
- Effects of Clostridium difficile toxin on tissue-cultured cells.
- Lack of polarity of DNA injection by Escherichia coli phage lambda.
- Physical studies of glycerol protection against x-ray inactivation of bacteriophage.
- Immunochemical relationships of chicken pepsinogens and pepsins.
- Chicken pepsinogens and pepsins. Their isolation and properties.
- Letter: Upper respiratory tract protocol.
- The growth of functional rat glial cells in a serumless medium.
- NBT test in Rocky Mountain spotted fever.
- In vitro production and inactivation of Escherichia coli enterotoxin.
- Effect of 5-fluorocytosine and amphotericin B on Candida albicans infection in mice.
- Tissue-culture assay of antibodies to heat-liable Escherichia coli enterotoxins.
- Stimulation of steroidogenesis in tissue culture by enterotoxigenic Escherichia coli and its neutralization by specific antiserum.
- Neutralization of cholera enterotoxin-induced steroidogenesis by specific antibody.
- Detection of heat-labile Escherichia coli enterotoxin with the use of adrenal cells in tissue culture.
- X-ray inactivation of bacteriophages: role of O 2 -dependent damage in single- and double-strand DNA phages.
- Comparison of the effects of cholera enterotoxin and ACTH on adrenal cells in tissue culture.
- Differentiation between the steroidogenic effects of cholera enterotoxin and adrenocorticotropin through use of a mutant adrenal cell line.
- Induction of steroidogenesis in tissue culture by cholera enterotoxin.
- Alteration of tyrosine aminotransferase activity in hepatoma cells in tissue culture by amphotericin B.
- Drug removal during continuous arteriovenous hemofiltration: theory and clinical observations.
- Comparative effects of gentamicin and tobramycin on excretion of N-acetyl-beta-D-glucosaminidase.
- Therapy of Mycobacterium marinum infections. Use of tetracyclines vs rifampin.
- Infective endocarditis due to penicillin-tolerant Streptococcus bovis.
- Tetracyclines in therapy of Mycobacterium marinum infections.
- Candida detection system (CAND-TEC) to differentiate between Candida albicans colonization and disease.
- Parenteral therapy for antibiotic-associated pseudomembranous colitis.
- Encephalomyocarditis virus can bind to and transfect non-permissive cells.
- Modulation of enterotoxin binding and function in vitro and in vivo.
- Reovirus type 3 binds to antagonist domains of the beta-adrenergic receptor.
- Binding of 125I-labelled tumor necrosis factor to Pneumocystis carinii and an insoluble cell wall fraction.
- Intravenous immunoglobulin therapy for toxic shock syndrome.
- Binding of class II Escherichia coli enterotoxins to mouse Y1 and intestinal cells.
- Morphological and steroidogenic changes in cultured adrenal tumor cells induced by a subunit of cholera enterotoxin.
- Editorial: Gastroenterologists on the move: the nature of travelers'' diarrhea.
- Growth of functional glial cells in a serumless medium.
- Inhibition of the steroidogenic effects of cholera and heat-labile Escherichia coli enterotoxins by GM1 ganglioside: evidence for a similar receptor site for the two t...
- Changing concepts of infectious diarrheas.
- The risk of diarrhea and colitis with antibiotic therapy.
- Serum antibody to Escherichia coli heat-labile enterotoxin in cattle and swine.
- Interactions of choleragenoid and GM1 ganglioside with enterotoxins of Vibrio cholerae and Escherichia coli in cultured adrenal cells.
- Cytotoxic activity of Aeromonas hydrophila.
- Mycobacterium gordonae infection of a prosthetic aortic valve.
- The efficacy of rifampin as adjunctive therapy in selected cases of staphylococcal endocarditis.
- Adherence of Enterobacteriaceae to human buccal cells.
- Effect of antibiotics on the adherence of enterobacteriaceae to human buccal cells.
- Antibody to Escherichia coli enterotoxin in meat-packing workers.
- Enterotoxigenic Escherichia coli and diarrheal disease in Mexican children.
- Replication of murine cytomegalovirus in murine Y-1 cells.
- Specificity of attachment of certain enterobacteriaceae to mammalian cells.
- Gap junctions and ACTH sensitivity in Y-1 adrenal tumor cells.
- Classification of enterotoxins on the basis of activity in cell culture.
Schools
A Einstein Col Med Yeshiva Univ
University Of Pittsburgh Hospitals
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
Boston University Medical Center -
University of Pittsburgh Medical Center -
Albert Einstein College of Medicine of Yeshiva University
Drug Facts
| NPI NUMBER | 1477502086 | |
| NPPES Provider LastName | DONTA | |
| NPPES Provider FirstName | SAM | |
| NPPES Provider ZIPCode | 025402533 | |
| NPPES Provider State | MA | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 687.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1477502086 |
| Last Name Of The Provider | DONTA |
| First Name Of The Provider | SAM |
| View All |